Litcius/Paper detail

Inducible degrader of LDLR: A potential novel therapeutic target and emerging treatment for hyperlipidemia

Qi Yu, Huadong Zheng, Yaping Zhang

2021Vascular Pharmacology14 citationsDOI

Topics & Concepts

PCSK9LDL receptorHyperlipidemiaStatinKexinMedicineUbiquitin ligaseProprotein convertaseUbiquitinPharmacologyCholesterolInternal medicineEndocrinologyBiologyDiabetes mellitusBiochemistryLipoproteinGeneLipoproteins and Cardiovascular HealthCancer, Lipids, and MetabolismCholesterol and Lipid Metabolism
Inducible degrader of LDLR: A potential novel therapeutic target and emerging treatment for hyperlipidemia | Litcius